The first trial to publish five-year results from SBRT treatment for
prostate cancer, found a 98.6 percent cure rate with SBRT, a
noninvasive form of radiation treatment that involves high-dose
radiation beams entering the body through various angles and
intersecting at the desired target. It is a state-of-the-art technology
that allows for a concentrated dose to reach the tumor while limiting
the radiation dose to surrounding healthy tissue.
"The high cure rate is striking when compared to the reported
five-year cure rates from other approaches like surgery or conventional
radiation, which range between 80 to 90 percent, while the side effects
of this treatment are comparable to other types of treatment," said Dr.
Raquibul Hannan, Assistant Professor of Radiation Oncology and lead
author for the study. "What we now have is a more potent and effective
form of completely noninvasive treatment for prostate cancer,
conveniently completed in five treatments.""The current form of radiation is 44 treatments given over nine weeks.
In contrast, the SBRT therapy we used allows the delivery of highly
focused radiation in only five treatments, allowing patients to return
to their normal lives more quickly,"
Since 2009, UT Southwestern has trained more than 300 physicians and
peers interested in implementing SBRT in their clinical practice.
Simmons Cancer Center's arsenal of stereotactic radiotherapy technology
includes the cutting-edge Gamma Knife, CyberKnife, Agility, Vero SBRT
and TrueBeam technologies.
No comments:
Post a Comment